Michael B. Jebsen
2014
In 2014, Michael B. Jebsen earned a total compensation of $5M as President, Chief Financial Officer at Tenax Therapeutics, a 1,152% increase compared to previous year.
Compensation breakdown
| Bonus | $225,000 |
|---|---|
| Non-Equity Incentive Plan | $176,150 |
| Option Awards | $3,954,628 |
| Salary | $309,375 |
| Stock Awards | $332,150 |
| Other | $9,600 |
| Total | $5,007,003 |
Jebsen received $4M in option awards, accounting for 79% of the total pay in 2014.
Jebsen also received $225K in bonus, $176.2K in non-equity incentive plan, $309.4K in salary, $332.2K in stock awards and $9.6K in other compensation.
Rankings
In 2014, Michael B. Jebsen's compensation ranked 1,550th out of 13,032 executives tracked by ExecPay. In other words, Jebsen earned more than 88.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,550 out of 13,032 | 88th |
Division Manufacturing | 554 out of 4,966 | 89th |
Major group Chemicals And Allied Products | 175 out of 1,686 | 90th |
Industry group Drugs | 136 out of 1,365 | 90th |
Industry Pharmaceutical Preparations | 116 out of 1,043 | 89th |
Source: SEC filing on August 17, 2015.
Jebsen's colleagues
We found one more compensation record of an executive who worked with Michael B. Jebsen at Tenax Therapeutics in 2014.
2014
John Kelley
Tenax Therapeutics